Inovio Pharmaceuticals (INO) Other Working Capital Changes (2010 - 2026)

Inovio Pharmaceuticals has disclosed Other Working Capital Changes across 17 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 8.35% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at -$1.9 million (down 57.7% YoY), while the FY2025 annual figure was -$1.1 million, up 58.89% from the prior year.
• Other Working Capital Changes came in at $1.5 million for Q2 2026 at Inovio Pharmaceuticals, up from -$852534.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $22.9 million in Q1 2018 to a low of -$23.4 million in Q2 2018.
• Average Other Working Capital Changes over 5 years is -$72920.1, with a median of -$28713.0 recorded in 2021.
• Year-over-year, Other Working Capital Changes jumped 257.08% in 2022 and tumbled 815.36% in 2024.
• Over 5 years, Other Working Capital Changes stood at -$13.8 million in 2022, then jumped by 101.92% to $264563.0 in 2023, then plunged by 815.36% to -$1.9 million in 2024, then dropped by 4.97% to -$2.0 million in 2025, then jumped by 174.54% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $1.5 million in Q2 2026, -$852534.0 in Q1 2026, and -$2.0 million in Q4 2025.